Skip to Main Content

Advertisement

Skip Nav Destination

PI-88, a novel heparanase inhibitor, as adjuvant therapy for hepatocellular carcinoma: A large randomized phase II clinical trial

Cancer Res (2007) 67 (9_Supplement): 2650.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal